After 68 weeks, the patient group treated with once weekly semaglutide 2.4mg (WeGovy) experienced significant weight loss of 14.9% body weight reduction versus 2.4% placebo group
That sounds reassuring, and clinically, for an undamaged liver, it is
Content Lose some, win some Reviewed by Craig Primack, MD, FACP, FAAP, FOMA Written by Vanessa Gibbs Published 01/31/2025 Updated 07/08/2025 Looking for support with weight loss
This plan will incorporate a wide range of health and lifestyle changes focused on diet and exercise
Your medication remains safe and effective if left out for up to 24 hours in normal indoor conditions (below 77F)
And also say we talked about this earlier